Numerous factors that can influence the proliferation and differentiation in vitro of cells at various stages of hematopoiesis have been identified, but the mechanisms used by stromal cells t o regulate the cycling status of the most primitive human hematopoietic cells are still poorly understood. Previous studies of long-term cultures (LTC) of human marrow have suggested that cytokine-induced variations in stromal cell production of one or more stimulators and inhibitors of hematopoiesis may be important. To identify the specific regulators involved, we performed Northern analyses on RNA extracted from human marrow LTC adherent layers, or stromal cell types derived from or related t o those present in the adherent layer. These analyses showed marked increases in interleukin-1p (IL-lp), IL-6, and granulocyte colony-stimulating factor (G-CSF) mRNA levels within 8 hours after treatments that lead t o the activation within 2 days of primitive hematopoietic progenitors in such cultures. Increases in granulocyte-macrophage (GM)-CSF and M-CSF mRNA were also sometimes seen. Bioassays using cell lines responsive t o G-CSF, GM-CSF, and IL-6 showed significant elevation in growth factor levels 24 hours after IL-1p stimula-HE MOST PRIMITIVE cells in the hematopoietic T system represent a quiescent reserve population with the potential for generating very large numbers of mature blood cells at a much faster rate than is normally required.'.' In vivo, this high proliferative potential is only expressed after various perturbations, as for example following transplantation of a small number of cells into a host whose hematopoietic system has been ablated by irradiation or chemotherapy. In this setting even single stem cells in a transplant can eventually reconstitute and maintain the entire lymphoid and myeloid system for many months:.' However, the endogenous mechanism(s) that promote or restrict the output of mature progeny from these transplantable hematopoietic stem cells in vivo are still largely unknown. One approach to the investigation of this area has focused on defining the in vitro responsiveness of very primitive hematopoietic cells whose behavior can be moni-tion. Neither IL-3 nor I L 4 mRNA was detectable at any time. In contrast, transforming growth factor-p (TGF-p) mRNA and nanogram levels of TGF-p bioactivity in the medium were detected at all times in established LTC, and these levels were not consistently altered by any of the manipulations that stimulated hematopoietic growth factor production and primitive progenitor cycling. We also found that addition of anti-TGF-p antibody could prolong or reactivate primitive progenitor proliferation when added t o previously stimulated or quiescent cultures, respectively. Together, these results indicate a dominant negative regulatory role of endogenously produced TGF-p in unperturbed LTC, with activation of primitive hematopoietic cells being achieved by mechanisms that stimulate stromal cells t o produce G-CSF, GM-CSF, and IL-6. Given the similarities between the LTC system and the marrow microenvironment, it seems likely that the control of human stem cell activation in vivo may involve similar variations in the production of these factors by stromal cells.
o 1991 by The American Society of Hematology. tored following exogenous factor addition. Both in vivo9 and in vitro3.10' 13 colony assays for progenitors of high proliferative and multi-lineage potential exist and, while it seems likely that most of the cells detected by these assays do not have totipotent long-term repopulating p~tential,'~'" they are thought to be closely related to such repopulating cells and to share an ability to alternate between a quiescent and a cycling state on demand.'.3x'3 Recent in vitro factor addition experiments have shown that several growth factors, including interleukin-6 (IL-6), granulocyte colonystimulating factor (G-CSF), and IL-3, can stimulate clonogenic hematopoietic progenitors with a high proliferative potential." Similarly, both transforming growth factor-p (TGF-P) and macrophage-inflammatory protein-la (MIPl a ) have been shown to have an ability to selectively inhibit the proliferation of such cell^.'^.^
To determine which of these factors might be involved in the mechanisms by which human hematopoietic cells are physiologically regulated within the marrow, we have analyzed their production and role in hematopoietically active long-term human marrow cultures (LTC). These cultures may be viewed as a model of the marrow microenvironment because they support the maintenance of high proliferative potential clonogenic progenitors for many weeks in the absence of exogenous hematopoietic growth factor addition if certain stromal cells are' p r e~e n t .~~~*~ In addition, it has been found that the primitive hematopoietic progenitors in the adherent layer of established cultures only proliferate when medium containing fresh horse serum (HS) or one of a variety of indirect acting mesenchymal cell stimulators, such as IL-lp or platelet-derived growth factor (PDGF), is added.21*" Because the effect of such treatments is shortlived, within a week the primitive hematopoietic progeni-tors in the adherent layer return to a quiescent state, although they can be repeatedly stimulated to proliferate by the same treatments. This unique proliferative behavior appears to be under the control of the stromal cells in the adherent layer because quiescence is only established when the two cell types are in close proximity." Therefore, we have proposed that both the support and turnover of very primitive hematopoietic cells in the marrow might be regulated by close-range interactions with mesenchymal stromal cell types that, according to their own state of activation, differentially vary their production of factors with positive and negative effects on primitive hematopoietic cells.
Recently, mRNA for granulocyte-macrophage (GM)-CSF has been demonstrated in extracts of LTC of murine marrow,= and a variety of human mesenchymal cell types related to the lineages represented in human marrow LTC adherent layers have been shown to increase their expression of GM-CSF, G-CSF, and IL-6 after exposure to IL-1 or PDGF.29 33 In addition, it has been shown that substantial amounts of GM-CSF can be extracted from the extracellular matrix in the adherent layer of human LTC.34 Induction of one or more of these factors would thus seem a likely part of the mechanism underlying the observed stimulation of primitive progenitors following stromal cell activation. Because the addition of exogenous TGF-f3 to human LTC can prevent the stimulation of high proliferative potential clonogenic cells? it also seemed possible that endogenous production of TGF-f3 by marrow stromal cells might contribute to the downregulation of proliferation of primitive hematopoietic cells in unperturbed LTC. To examine these possibilities, we undertook time-course studies of the mRNA and bioactivity levels of these and other factors in the adherent layer of LTC and performed anti-TGF-f3 antibody neutralization studies
MATERIALS AND METHODS

Cells and reagents.
Marrow was obtained in heparinized medium from informed and consenting normal donors of allogeneic transplants. MH2SV1, CFU-ST16, and U9.1 cells are cloned lines of marrow "stromal" cells with features of both fibroblasts and endothelial cells isolated independently in this laboratory by SV-40 transformation of three different human marrow cell culture^?^ HUV-EC-C cells are human umbilical cord vein endothelial cells originally obtained from the American Type Tissue Collection (ATCC, Rockville, MD). Purified porcine TGF-PI and an affinitypurified rabbit antiporcine TGF-p, antibody preparation were purchased from R & D Systems (Minneapolis, MN). ABnitypurified Ig from normal rabbit serum was used as a control. Purified human PDGF was purchased from Collaborative Research (Bedford, MA), purified TGF-a from Bachem (Torrance, CA), and purified human epidermal growth factor (EGF) from Boehringer Mannheim (Montreal, Quebec, Canada). Purified recombinant human IL-lp was kindly provided by Biogen (Boston, MA).
LTC were established in 60-mm tissue culture dishes (or appropriately scaled up in 150-cm2 flasks) from unprocessed marrow aspirate cells, maintained, stimulated, harvested by trypsinization, and assayed in methylcellulose for high proliferative potential erythroid and granulopoietic progenitors (referred to as primitive burst-forming unit-erythroid [BFU-E] and colony-
Cultures.
forming unit-GM [CFU-GM]) using procedures that are routine in this laboratory and that have been described in detail previously?6 Standard LTC medium consists of an enriched a medium plus 12.5% HS, 12.5% fetal calf serum (FCS), mol/L 2-mercaptoethanol, and mol/L hydrocortisone sodium hemisuccinate. For RNA studies of adherent layer cells, nonadherent cells were simply decanted and the adherent layer was then scraped off with a rubber policeman, pelleted, and RNA extracted as described below. Marrow "fibroblasts" were obtained by repeated trypsinization and subculturing of marrow cells as soon as they reached confluence in tissue culture dishes containing a medium plus 15% FCS. SV-40 transformed marrow cell lines were similarly maintained in a medium plus 15% FCS. HUV-EC-C cells were maintained in F12K medium supplemented with endothelial cell growth factor (Collaborative Research, Bedford, MA) and 15% FCS as recommended by ATCC.
Suspended LTC adherent layer cells were washed and incubated for 20 minutes at 37°C in medium with or without high specific activity 'H-thymidine before plating in methylcellulose and subsequent derivation of 'H-thymidine suicide (% kill) values from colony counts in the two groups, exactly as in previous studies of this Northern anabses. Total cellular RNA was isolated using the guanidinium isothiocynate pr~cedure?~.'~ RNA was separated by electrophoresis through 1.2% agarose gels containing 5% formaldehyde and transferred to Zetaprobe nylon membranes (Bio-Rad Laboratories, Richmond, CA) by centrif~gation.~~ Filters were hybridized and washed at high stringency as de~cribed.'~ The following gel-purified DNA fragments were used to synthesize probes: the 1,050-bp EcoRI fragment of ApCl containing most of a human TGF-p cDNA4'; the 900-bp Xho I fragment of pXMIL3 containing the complete coding region of a human IL-3 cDNA4'; the 900-bp insert of the pp2.15 human IL-6 partial cDNA4'; the 5' 450-bp fragment of a human GM-CSF cDNA cloned in our laboratory with the same sequence as previously reported"; the 200-bp HindIII-PvuII fragment of a human IL-1p c D N A~; the 900-bp Xho I fragment of p~D1L-4~' containing a complete IL-4 cDNA, the 1,050-bp BgII-PstI fragment of a human M-CSF c D N A~~; and the 1,200-bp PstI fragment of a chicken p-actin cDNA:~ Probes were labeled by hexamer priming as previously described." TGF-p bioactivity was assayed by induction of anchorage-independent growth by NRK fibroblasts using a slight modification of the method described by Assoian et ar9 in which methylcellulose was substituted for agar to provide a semisolid matrix. Briefly, NRK cells were suspended in a 0.8% methylcellulose culture medium containing 10% FCS and 2.5 ng/mL EGF and either TGF-p standard as a control, or test material, to give a final concentration of 3,500 cells/mL. One-milliliter aliquots were then plated in 35-mm Petri dishes (Greiner, Nurtingen, Germany) which fail to support any anchorage-dependent fibroblast growth even in liquid medium. Cultures were incubated for 14 days in a humidified atmosphere of 5% CO, in air before scoring of colonies containing 20 or more cells. Results shown are for test conditioned media harvested as described in the text and stored at -20°C. Occasional samples were also subjected to acidification (pH 2.0) by addition of HCl and then adjustment of the pH to 7.0 by the further addition of NaOH as described'" to assess potential TGF-p precursor activity. The level of TGF-p detected in these instances was not different than preacidification levels (data not shown). Culture supernatants were also assayed for growth factor bioactivities by quantitation of "-thymidine incorporation into appropriate responsive cells: AML-193" (for GM-CSF), NFS-60" (for G-CSF), Thymidine suicide assays.
Bioactivity assays.
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Functional role of endogenous TGF-p in human marrow LTC.
To test the potential role of endogenously derived TGF-P in regulating primitive hematopoietic progenitor proliferation in LTC, a series of experiments using neutralizing anti-TGF-p antibody were next undertaken. The two experimental protocols followed are shown schematically in Fig 4. In the first, anti-TGF-p antibody was added 3 days after a regular half-medium change. At this time primitive BFU-E and CFU-GM in the adherent layer are maximally cycling, but then normally return to a quiescent state within another 4 days.26 As shown in Fig 5, the effect of adding anti-TGF-P antibody according to this protocol was to maintain the majority of primitive BFU-E and CFU-GM in the adherent layer in S-phase when antibody concentrations of 25 p,g/mL or more were used, ie, amounts sufficient to neutralize at least 2.5 ng/mL of TGF-P according to data provided by the supplier. The effect of adding anti-TGF-p antibody in this type of experiment was consistent in all eight experiments performed, was specific, and could be reversed by the simultaneous addition of a competitive concentration of TGF-P (Table 3) . These results suggest that neutralization of sufficient endogenous TGF-P in recently activated cultures can maintain the ratio of directacting positive factors to TGF-P in favor of the former, thereby allowing the primitive progenitors to continue to proliferate.
In the second protocol (Fig 4) , addition of anti-TGF-p antibody was delayed until 7 days after the previous half-medium change, ie, at the time when another halfmedium change would normally be performed. At this time primitive BFU-E and CFU-GM in the adherent layer are quiescent. The purpose of this design was to determine whether neutralization of TGF-p in such cultures could be sufficient to allow these quiescent progenitors to be reactivated, thereby testing whether the effects achieved in the first protocol might be dependent, not only on the absolute concentration of TGF-p present in the cultures ( Table 2) , but also on the level of positive stimulators of primitive progenitor proliferation present at the same time. The results of each of a total of six experiments performed using the second anti-TGF-P addition protocol are shown individually in Table 4 . In three of these experiments (arbitrarily listed first), neutralization of endogenous TGF-P resulted in the reentry into S-phase of the primitive BFW-E and CFU-GM that had already become quiescent before the addition of anti-TGF-P antibody. In the other three experiments (listed last), these same progenitor types remained quiescent, suggesting inadequate levels of positive stimulators to counter residual levels of TGF-P and/or other possible inhibitors in these particular cultures.
DISCUSSION
Cells with a mesenchymal phenotype sharing features of fibroblasts and endothelial cells constitute a major component of the adherent layer that forms in LTC initiated with human m a~r o w .~~-'~ Such cells are also present as fixed (noncirculating) elements in vivo:' where they have been implicated for many years as playing a primary role in locally regulating hematopoietic cell turnover in the mar-Additional evidence for this has come from studies of For personal use only. on July 15, 2017. by guest www.bloodjournal.org From Table 4 mice bearing mutant alleles at the Steel (Sl) locus. The macrocytic anemia and defective stem cell function seen in these mice are due to a deficient hematopoietic microenvironment that can only be repaired by the transfer of whole tissue fragments:'@ Very recently the molecular basis of this deficiency has been characterized as an abnormality in the production of a multi-lineage growth factor that is produced by fibroblasts and that may exist in a membranebound f~r m .~' -~~ Fibroblasts and endothelial cells also produce several other growth factors active on hematopoietic cell^?^-^^ Further evidence that the physiologic regulation of hematopoiesis is achieved through the control of locally effective growth factors has been obtained from studies of the LTC system. These studies have shown that hematopoiesis cannot be sustained in LTC lacking a stromal cellcontaining adherent layer or containing a defective adherent layer of Sl/Sld rigi in.^^,^.^^ Another function of the stromal cells in the adherent layer is to return adjacent (but not nonadherent) primitive hematopoietic cells to a quiescent state in unperturbed cultures.27
. Anti-TGF-p Antibody (Ab) Has a Variable Effect on Already-Quiescent Primitive Progenitors in LTC Adherent Layers (protocol 2)
In this report we have presented evidence that the downregulating activity of the stromal cells in LTC may be attributed at least in part to their constitutive production and release of bioactive TGF-P. TGF-P was a probable candidate for such a role as it had previously been shown to act directly, reversibly, and selectively to arrest or prevent the proliferation in vitro of the type of primitive hematopoietic cells that are normally quiescent in the marrow in vivo?' In LTC initiated with murine marrow, myelopoiesis could be permanently arrested by exogenous TGF-P addition.66 Thus, it seems likely that TGF-P produced by stromal cells within the marrow microenvironment will be found to play an important role in downregulating primitive hematopoietic cell turnover in vivo. Recently, another factor, MIP-la, has been identified to have a similarly selective and reversible cytostatic action on primitive hematopoietic cells in s~s p e n s i o n .~~~~' Whether or not endogenously derived MIP-la contributes to the mechanism of primitive progenitor regulation either in the adherent layer of human LTC or in vivo is not yet known, although preliminary studies indicate that MIP-la mRNA can be readily detected in human LTC adherent layer cells (unpublished data, Novem-ber 1990). Nevertheless, the data reported here would already suggest that MIP-la alone cannot account for the observed downregulation of primitive hematopoietic cells in human LTC.
The present experiments have shown a concordance in the timing of G-CSF, GM-CSF, M-CSF, IL-lP, and IL-6 activation in stromal cells with the stimulation of primitive hematopoietic progenitor cycling in human LTC. These findings suggest that one or more of these factors, alone or together with as yet unidentified factors produced by stromal cells (eg, the growth factor produced by the S1 gene63), may be direct positive mediators of primitive progenitor activation in the LTC system. More recent experiments using stromal cell feeders that have been genetically engineered to constitutively release elevated levels of factors have shown G-CSF, but not GM-CSF, to serve this function. 67 The present studies show that primitive progenitor cycling changes can be correlated not only with an upregulation in stimulator production in the absence of any change in TGF-P levels, but also with a decrease in TGF-P levels even when stimulator production is declining. Therefore, it seems that at the level of the responsive target cell, it is the relative rather than the absolute concentration of positive and negative factors to which the cell is exposed that is important. The ultimate response then obtained will be determined by the intrinsic sensitivity of the cell to both factors and their relative concentrations in the environment. The former would account for differential responses of developmentally distinct stages of hematopoietic cell differentiation, with earlier stages favoring quiescence (high sensitivity to TGF-P, low sensitivity to positive regulators) and later stages favoring proliferation (lower sensitivity to TGF-P and increased sensitivity to positive regulators). Appropriate changes in extracellular factor levels would, nevertheless, allow all stages of hematopoietic cell development to be altered by changing circumstances. 96, 1990 22. Graham GJ, Wright EG, Hewick R, Wolpe SD, Wilkie NM, Donaldson D, Lorimore S, Pragnell IB: Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature 344: 442, 1990 23. Broxmeyer HE, Sherry B, Lu L, Cooper S, Oh K-0, Tekamp-Olson P, Kwon BS, Cerami A Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood 76: 1110, 1990 24. Coulombel L, Eaves AC, Eaves CJ: Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer. Blood 62:291,1983 25. Sutherland HJ, Lansdorp PM, Henkelman DH, Eaves AC, Eaves CJ: Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci USA 87: 3584, 1990 26 
